On June 20, 2025, Novavax Inc. held its Annual Meeting where stockholders voted on multiple proposals, including the election of directors and approval of executive officer compensation, with 95,359,194 shares represented. The proposals passed, including the election of Rachel K. King, John W. Shiver, and Charles W. Newton as directors with significant support.